Since it was first sequenced, the human genome has led resea...
Read More Dark DNA Could Hold Clues to Rare Neurological Disease and Disease Prediction

Since it was first sequenced, the human genome has led resea... by Shreya Krishnamurthy / 01.11.2018
Read More Dark DNA Could Hold Clues to Rare Neurological Disease and Disease Prediction
Thermo Fisher Scientific and Illumina Sign Agreement to Prov... by Behind The Bench Staff / 01.08.2018
Read More Expanding Access to Ion AmpliSeq Technology
For Dr. Luca Quagliata, senior director at the University Ho... by Shreya Krishnamurthy / 12.18.2017
Read More SeqStudio for Translational Research at the University Hospital of Basel
The SeqStudio Genetic Analyzer brings speed, accuracy and ea... by Shreya Krishnamurthy / 11.24.2017
Read More SeqStudio Speed and Accuracy for Inherited Disease Research
Andre Samuel runs the Citizen Science Lab, Pittsburgh’s on... by Shreya Krishnamurthy / 11.09.2017
Read More SeqStudio Enables Community STEM Outreach at Pittsburgh’s Citizen Science Lab
Ancestry informative markers (AIMs) are polymorphisms that h... by Angie Lackey / 11.08.2017
Read More What Can We Learn About Admixed Populations Using Global Ancestry Informative Markers?
Joydeep Goswami, president of Clinical Next Generation Seque... by Behind The Bench Staff / 10.30.2017
Read More Capitol Hill Briefing Sheds Light on Advancements and Hurdles Surrounding Molecular Diagnostics
The availability of a next-generation sequencing (NGS) assay... by Behind The Bench Staff / 10.27.2017
Read More NGS Assays Using cfDNA Input is Enabling Cancer Researchers to Accelerate their Work
In June, the FDA approved the first next-generation sequenci... by Behind The Bench Staff / 10.16.2017
Read More Q&A with Joydeep Goswami on the Oncomine Dx Target Test
“A comprehensive panel is essential to obtain a good y... by Behind The Bench Staff / 10.16.2017
Read More Finding Causative and Actionable Variants in Inherited Disease Research Studies—Targeted Sequencing vs. Whole Exome